Neural signatures of risk-taking adaptions across health, bipolar disorder, and lithium treatment
Scholl J. et al, (2025), Molecular Psychiatry
Can liaison neurology add value to patient care within a mental health setting?
Ward JH. et al, (2025), The British Journal of Psychiatry, 226, 47 - 48
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
de Cates AN. et al, (2024), The British Journal of Psychiatry, 1 - 8
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study
De Giorgi R. et al, (2024), eClinicalMedicine, 74, 102726 - 102726
The recombinant shingles vaccine is associated with lower risk of dementia.
Taquet M. et al, (2024), Nat Med
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Taquet M. et al, (2024), Brain Commun, 6
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Harrison PJ. and Bannerman DM., (2023), Molecular Psychiatry
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Taquet M. et al, (2023), Nat Med
Sex and age effects on risk of non-traumatic subarachnoid hemorrhage: Retrospective cohort study of 124,234 cases using electronic health records
Harrison CH. et al, (2023), Journal of Stroke and Cerebrovascular Diseases, 32, 107196 - 107196
Data-driven Taxonomy for Antipsychotic Medication: A New Classification System
McCutcheon R., (2023), Biological Psychiatry
Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis
Taquet M. et al, (2023), Neurology, 100, e790 - e799
Little evidence supports gabapentinoid use in bipolar disorder or insomnia.
Saul H. et al, (2022), BMJ (Clinical research ed.), 379
Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience.
PANAGI M. et al, (2022), Molecular Psychiatry
CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology.
Harrison PJ. et al, (2022), Neuropharmacology
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
Al-Diwani A. et al, (2022), Brain, 145, 2742 - 2754
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M. et al, (2022), Lancet Psychiatry
New drug targets in psychiatry: Neurobiological considerations in the genomics era.
Harrison PJ. et al, (2022), Neurosci Biobehav Rev, 139